Sky Power Solutions (OTC.BB: SPOW) reached up 87.25% in morning trading to $.094 with 750K shares traded. Sky Power Solutions Corp., with Nevada incorporation was founded in 2004 and is a development stage technology company that is focusing its resources and efforts on the development and marketing of lithium-powered vehicles, products, and commercial and residential properties. Everything from scooters, bicycles, mopeds, motorcycles, cars and homes are being converted successfully to zero-emission, lithium-powered vehicles and facilities. Sky Power Solutions (OTC.BB: SPOW.OB - News) announced they have achieved significant advancements in the area of heat dissipation utilizing proprietary technology, combing two components into one unit enhancing the overall operation and functional aspect of the device.
Next 1 Interactive, Inc. (OTCBB:NXOI) reached up 20% in morning trading to $.0012 with 52M shares traded. Next 1 Interactive, Inc. is a multi faceted media company specializing in Travel and Real Estate. Next 1 plans the delivery of targeted content via multiple digital platforms including Satellite, Cable, Broadcast, Broadband and Mobile. In today's digital market Next 1 delivers information and entertainment to consumers. The company business plan calls for multiple revenue streams from real estate and travel content delivery including transactional commissions, referral fees, advertising and sponsorship. The multiple revenue streams and integrated media platforms allow for the delivery of measurable return on investment to its advertisers, sponsors and business partners. Next 1 Interactive, Inc. (OTCBB:NXOI.OB - News), ("Next 1") announced today, it has entered into an agreement with 3RDHome.com to allow Next 1 to offer additional travel options and incentives to both its customers and 3RD Home vacation home owners.
Genesis Biopharma, Inc. (OTCBB: GNBP) Big News Out from Company Today! Genesis Biopharma, Inc. is engaged in the development and commercialization of autologous cell therapies for the treatment of various cancers. The Company's lead product candidate, Contego™, is a ready-to-infuse autologous cell therapy utilizing tumor infiltrating lymphocytes for the treatment of patients with Stage IV metastatic melanoma. Contego™ is based on a currently available physician-sponsored investigational therapy at the National Cancer Institute, MD Anderson Cancer Center and the H. Lee Moffitt Cancer & Research Institute for the treatment of Stage IV metastatic melanoma. Genesis Biopharma, Inc. (OTC/BB: GNBP) today announced that Hans E. Bishop has been named Executive Chairman of the Company's Board of Directors. Mr. Bishop has served as a Director of the Company since January 2012. Anthony J. Cataldo, formerly the Chairman of the Board, will remain as a Director of the Company.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
